iCan o3 CGM System
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for iCan o3 CGM System, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period [NA]